Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China flag China · Delayed Price · Currency is CNY
11.78
-0.34 (-2.81%)
May 20, 2026, 1:35 PM CST

SHE:300705 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,0073,1082,9302,6912,3251,627
Other Revenue
2.792.791.151.020.890.82
3,0103,1112,9312,6932,3261,628
Revenue Growth (YoY)
-0.85%6.15%8.85%15.75%42.92%66.40%
Cost of Revenue
862.53849.11790.88621.79522.52365.47
Gross Profit
2,1482,2622,1402,0711,8041,262
Selling, General & Admin
1,4661,4701,3311,4051,285878.31
Research & Development
189.5218.41245.97254.12201.26146.26
Other Operating Expenses
25.9928.725.1528.4725.8721.04
Operating Expenses
1,6831,7181,5981,6961,5251,051
Operating Income
464.54543.69541.62375.12278.84211.22
Interest Expense
-18.42-14.99-18.63-11.06-18.42-16.01
Interest & Investment Income
1.832.468.567.676.85.82
Currency Exchange Gain (Loss)
-0.06-0.06-0.26-0.42-0.27-0.14
Other Non Operating Income (Expenses)
-22.02-23.8-0.58-0.29-0.24-0.19
EBT Excluding Unusual Items
425.87507.31530.71371.02266.71200.7
Gain (Loss) on Sale of Investments
-1.4-0.96----
Gain (Loss) on Sale of Assets
-0.070.05-0.03-0.02
Asset Writedown
-4.37-4.22-1.92-1.46-1.3-1.9
Other Unusual Items
24.2224.1843.432.5724.8127.38
Pretax Income
444.26526.36572.19402.16290.22226.19
Income Tax Expense
45.7356.3359.8233.920.5221.94
Earnings From Continuing Operations
398.52470.04512.38368.26269.7204.25
Minority Interest in Earnings
5.262.78----
Net Income
403.78472.82512.38368.26269.7204.25
Net Income to Common
403.78472.82512.38368.26269.7204.25
Net Income Growth
-21.21%-7.72%39.13%36.55%32.05%148.29%
Shares Outstanding (Basic)
496493488478460461
Shares Outstanding (Diluted)
501498493504460461
Shares Change (YoY)
0.93%1.02%-2.34%9.55%-0.15%0.13%
EPS (Basic)
0.810.961.050.770.590.44
EPS (Diluted)
0.810.951.040.730.590.44
EPS Growth
-21.94%-8.65%42.47%24.64%32.24%147.98%
Free Cash Flow
-64.97-5.83348.54.37-144.3964.94
Free Cash Flow Per Share
-0.13-0.010.710.01-0.310.14
Dividend Per Share
0.4000.4000.3130.2290.1690.133
Dividend Growth
27.81%27.81%36.49%36.00%26.67%507.76%
Gross Margin
71.35%72.70%73.01%76.91%77.54%77.55%
Operating Margin
15.43%17.48%18.48%13.93%11.99%12.98%
Profit Margin
13.41%15.20%17.48%13.68%11.59%12.55%
Free Cash Flow Margin
-2.16%-0.19%11.89%0.16%-6.21%3.99%
EBITDA
591.45664.19636.49446.5338.49264.8
EBITDA Margin
19.65%21.35%21.72%16.58%14.55%16.27%
D&A For EBITDA
126.91120.594.8771.3759.6453.58
EBIT
464.54543.69541.62375.12278.84211.22
EBIT Margin
15.43%17.48%18.48%13.93%11.99%12.98%
Effective Tax Rate
10.29%10.70%10.45%8.43%7.07%9.70%
Revenue as Reported
3,0103,1112,9312,6932,3261,628
Advertising Expenses
-39.6479.6473.0177.4128.51
Source: S&P Global Market Intelligence. Standard template. Financial Sources.